Pharvaris N.V.
PHVS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $97 |
| Gross Profit | $0 | $0 | $0 | -$97 |
| % Margin | – | – | – | – |
| R&D Expenses | $29,815 | $29,608 | $30,914 | $33,281 |
| G&A Expenses | $9,850 | $10,765 | $11,272 | $0 |
| SG&A Expenses | $9,850 | $10,765 | $11,272 | $14,722 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | -$84,373 | $0 |
| Operating Expenses | $39,664 | $40,373 | -$42,186 | $48,002 |
| Operating Income | -$39,664 | -$40,373 | $42,186 | -$48,099 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $2,346 | -$4,905 | -$88,224 | $12,342 |
| Pre-Tax Income | -$37,319 | -$45,278 | -$46,038 | -$35,757 |
| Tax Expense | -$181 | $203 | $303 | $1,322 |
| Net Income | -$37,137 | -$45,481 | -$46,341 | -$37,079 |
| % Margin | – | – | – | – |
| EPS | -0.6 | -0.83 | -0.85 | -0.64 |
| % Growth | 27.7% | 2.4% | -32.8% | – |
| EPS Diluted | -0.6 | -0.83 | -0.85 | -0.64 |
| Weighted Avg Shares Out | 62,256 | 54,688 | 54,519 | 54,070 |
| Weighted Avg Shares Out Dil | 62,256 | 54,688 | 54,519 | 54,070 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2,151 | $1,001 | $1,197 | $1,295 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $105 | $103 | $105 | $97 |
| EBITDA | -$37,213 | -$40,270 | -$42,081 | -$35,639 |
| % Margin | – | – | – | – |